Jasper Therapeutics (JSPR) Restructuring Costs (2020 - 2025)
Jasper Therapeutics (JSPR) posted quarterly Restructuring Costs of $15.8 million for Q2 2025, up 154.05% year-over-year from $6.2 million in Q2 2024, and up 61.57% quarter-over-quarter from $9.8 million in Q1 2025.
Jasper Therapeutics (JSPR) Restructuring Costs (2020 - 2025) Analysis & Trends
Jasper Therapeutics' Restructuring Costs history runs 5 years deep, the most recent figure standing at $15.8 million for Q2 2025.
- In Q2 2025, Restructuring Costs rose 154.05% year-over-year to $15.8 million; the TTM figure through Jun 2025 stood at $37.8 million (up 185.16% YoY), while the FY2024 annual figure was $34.3 million, down 6.82% from the prior year.
- Restructuring Costs for Q2 2025 stood at $15.8 million, up from $9.8 million in the prior quarter.
- The five-year high for Restructuring Costs was $15.8 million in Q2 2025, with the low at $80000.0 in Q3 2021.
- The 4-year median for Restructuring Costs is $480000.0 (2022), against an average of $3.6 million.
- The sharpest annual moves came in 2021 and 2022: Restructuring Costs sank 52.94% in 2021, then surged 493.75% in 2022.
- Jasper Therapeutics' Restructuring Costs stood at $99000.0 in 2021, then soared by 379.8% to $475000.0 in 2022, then surged by 1206.74% to $6.2 million in 2024, then surged by 154.05% to $15.8 million in 2025.
- Business Quant data shows JSPR's Restructuring Costs at $15.8 million in Q2 2025, $9.8 million in Q1 2025, and $6.2 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Jasper Therapeutics | 20.06 Mn | 20.06 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 15.77 Mn |
| Mar 31, 2025 | 9.76 Mn |
| Jun 30, 2024 | 6.21 Mn |
| Mar 31, 2024 | 6.11 Mn |
| Sep 30, 2022 | 475,000.00 |
| Jun 30, 2022 | 480,000.00 |
| Mar 31, 2022 | 556,000.00 |
| Dec 31, 2021 | 99,000.00 |
| Sep 30, 2021 | 80,000.00 |
| Jun 30, 2021 | 129,000.00 |
| Mar 31, 2021 | 128,000.00 |
| Dec 31, 2020 | 172,000.00 |
| Sep 30, 2020 | 170,000.00 |